Data from: Unraveling B-lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets

Bruna Klein Da Costa, Renata Brant De Souza Melo, Giordani Rodrigues Dos Passos, Douglas Gomes Meneses Sevilha Castro, Jefferson Becker, Amit Bar-Or & Douglas Kazutoshi Sato
Specific therapies targeting B lymphocytes in multiple sclerosis (MS) have demonstrated reductions in disease activity and disability progression. Several observational studies have also shown the effects of targeting B lymphocytes in other rare CNS inflammatory diseases, such as neuromyelitis optica spectrum disorder (NMOSD) and autoimmune encephalitis (AE). However, some drugs targeting cytokine receptors involved in B-lymphocyte maturation and proliferation resulted in negative outcomes in MS. These apparently conflicting findings have stimulated research on the pathophysiologic...
1 citation reported since publication in 2020.
47 views reported since publication in 2020.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?
5 downloads reported since publication in 2020.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?